Gut Peptide Receptors in Human Pancreatic Cancer
Author Information
Author(s): C Tang, I Biemond, GJA Offerhaus, W Verspaget, CBHW Lamers
Primary Institution: University Hospital Leiden, The Netherlands; Academic Medical Center, Amsterdam, The Netherlands
Hypothesis
The expression of gut peptide receptors in pancreatic cancer differs from that in tumour-free pancreas.
Conclusion
The study found that receptors for gut peptides are present in only a minority of pancreatic cancer specimens.
Supporting Evidence
- CCK-B receptors were not detected in any of the pancreatic cancers.
- BBS receptors were absent in 10 of 12 pancreatic cancers.
- Secretin receptors were visualized in 5 of 12 pancreatic cancers.
- VIP receptors were identified in 3 of 12 pancreatic cancer specimens.
Takeaway
This study looked at how certain receptors in the pancreas work differently in cancer compared to healthy tissue.
Methodology
The study used storage phosphor autoradiography to visualize and compare gut peptide receptors in tissue sections from healthy and cancerous pancreas.
Limitations
The study only included a small number of pancreatic cancer specimens and did not explore all potential receptor types.
Participant Demographics
10 control patients (6 men, 4 women) with an average age of 50 years; 12 pancreatic cancer patients (7 men, 5 women) with an average age of 66 years.
Want to read the original?
Access the complete publication on the publisher's website